Diclofenac Sodium and Misoprostol Delayed Release Tablets 75 mg/0.2 mg, 60-count bottle, Rx Only,...

FDA Drug Recall #D-0826-2018 — Class II — April 20, 2018

Recall Summary

Recall Number D-0826-2018
Classification Class II — Moderate risk
Date Initiated April 20, 2018
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Exela Pharma Sciences LLC
Location Lenoir, NC
Product Type Drugs
Quantity 5256 bottles

Product Description

Diclofenac Sodium and Misoprostol Delayed Release Tablets 75 mg/0.2 mg, 60-count bottle, Rx Only, Manufactured by: Cipla Ltd., India; For: EAGLE PHARMACEUTICALS, INC., Woodcliff Lake, NJ 07677 USA, NDC 42367-111-06.

Reason for Recall

Labeling: Label Mix-Up: bottle labeled as Diclofenac Sodium and Misoprostol 75 mg/0.2 mg contained Diclofenac Sodium and Misoprostol 50 mg/0.2 mg tablets.

Distribution Pattern

Nationwide in the USA and Puerto Rico

Lot / Code Information

Lot: GH70154, Exp 12/18

Other Recalls from Exela Pharma Sciences LLC

Recall # Classification Product Date
D-0620-2025 Class II 4.2% Sodium Bicarbonate Injection, USP, 5 mEq/1... Jul 30, 2025
D-0303-2025 Class II 8.4% Sodium Bicarbonate Injection, USP, 50 mEq/... Mar 7, 2025
D-0118-2024 Class I ELCYS (cysteine hydrochloride injection), USP, ... Oct 18, 2023
D-0116-2024 Class I 8.4% Sodium Bicarbonate Injection, USP, 50 mEq/... Oct 18, 2023
D-0117-2024 Class I Midazolam in 0.8% Sodium Chloride Injection 100... Oct 18, 2023

Frequently Asked Questions

Stop using the medication immediately and contact your pharmacist. A mislabeling recall can range from a minor technical error (wrong font size) to a serious mix-up where one drug is inside another drug's packaging. If you received a medication that looks or acts differently than expected, or if you experienced unexpected effects, tell your doctor immediately. The pharmacist can verify whether your specific lot is affected and provide a replacement. Report any adverse effects experienced to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.